ConductScience.org, home

Paper984801

Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.

Verbist L. Antimicrob Agents Chemother, 1976. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli. Papers, record 984801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/984801

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
3.57
iCite
Revised in PubMed
2021-05-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Verbist LL

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
CephalosporinsMajor topic
EnterobacteriaceaeMajor topic
Microbial Sensitivity Tests

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115830480Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15830480PubMed
21167042In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1167042PubMed
315828189Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15828189PubMed
415828188Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15828188PubMed
5238925A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals.J Antibiot (Tokyo)1975https://conductscience.org/library/papers/238925PubMed
64840447Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4840447PubMed
74790616Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790616PubMed
8769679In vitro studies of cefamandole.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/769679PubMed
9949175Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/949175PubMed
101267441Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1267441PubMed
111259407Cefuroxime, a new cephalosporin antibiotic: activity in vitro.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1259407PubMed
121259406Comparative study of the in vitro antibacterial activity of cefoxitin, cefuroxine, and cephaloridine.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1259406PubMed
131137392Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1137392PubMed
141137381BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1137381PubMed
1515830475Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15830475PubMed

Download CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
20919425Cefuroxime in the treatment of bacterial infections in seriously ill patients admitted to an intensive care unit.Proc R Soc Med1977https://conductscience.org/library/papers/20919425PubMed
20919382Cefuroxime: a clinical evaluation.Proc R Soc Med1977https://conductscience.org/library/papers/20919382PubMed
7027924Chemoprophylaxis with cefoxitin and cephalothin in orthopedic surgery: a comparison.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7027924PubMed
671221Pharmacokinetics of cefamandole using a HPLC assay.J Pharmacokinet Biopharm1978https://conductscience.org/library/papers/671221PubMed
478651The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides.Infection1979https://conductscience.org/library/papers/478651PubMed
475369In vitro of cefotaxime against cephalothin-resistant clinical isolates.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/475369PubMed
437897[In vitro testing of newer cephalosporins (author's transl)].Infection1979https://conductscience.org/library/papers/437897PubMed
369806Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.Drugs1979https://conductscience.org/library/papers/369806PubMed
348096Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic bacteria.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/348096PubMed
311615Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/311615PubMed
122524Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/122524PubMed
37064Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.Drugs1979https://conductscience.org/library/papers/37064PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/984801

GET https://conductscience.org/api/papers/v1/984801/authors